Our team researches health economics and clinical outcomes to assess the health technology. Health technology assessment (HTA) process has been implemented in Japan since April 2019 to provide the public with the best possible health outcomes at affordable costs. Our team aims at supporting pharmaceutical and medical device companies to provide patients with innovative health technology from clinical, societal, humanistic and economic point of view

Our Edge in Health Economic and Outcomes Research

Specialists in Health Economic and Outcomes Research (HEOR) and Databases

• Our HEOR specialists are well experienced in cost-effectiveness analysis (CEA), and they can provide services including budget impact analysis (BIA) and Real World Data analysis.
• Out team collaborates with data scientists who are expert in NDB Japan and other commercial databases.

Services

• Cost-effectiveness analysis
• Cost-benefit analysis
• Cost of illness
• Budget impact analysis
• Protocol review